AREX Capital Expresses Disappointment In Enhabit's Strategic Review Conclusion; Believes Enhabit's Shares Do Not Reflect Its Intrinsic Value Or Strategic Potential
AREX Capital Expresses Disappointment In Enhabit's Strategic Review Conclusion; Believes Enhabit's Shares Do Not Reflect Its Intrinsic Value Or Strategic Potential
Believes Enhabit's Shares Do Not Reflect its Intrinsic Value or Strategic Potential
認爲Enhabit的股票並不能反映其內在價值或戰略潛力
Has Nominated Seven Highly Qualified Independent Directors
已提名七名高素質獨立董事
Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise
相信AREX Slate將爲董事會提供急需的家庭健康和臨終關懷專業知識
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP ("AREX Capital Management" or "we"), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE:EHAB) (the "Company" or "Enhabit"), today issued the below statement expressing its disappointment in the conclusion of Enhabit's strategic review.
紐約，2024年5月9日（環球新聞專線）——AREX資本管理有限責任公司（“AREX資本管理” 或 “我們”）及其關聯公司——Enhabit, Inc.（紐約證券交易所代碼：EHAB）（“公司” 或 “Enhabit”）約4.8％股份的所有者今天發表了以下聲明，對Enhabit戰略審查的結論表示失望。
"We are disappointed that Enhabit's strategic review process has concluded without a sale of the Company. We do not believe that this failure reflects Enhabit's intrinsic value or strategic potential. Rather, this failure lies with Enhabit's Board. In March, we nominated a slate of seven highly qualified candidates to stand for election at the 2024 Annual Meeting. We chose not to publicly disclose our nomination to avoid disrupting the strategic review process to the detriment of shareholders, but clearly our hope that this Board might finally deliver a positive result for its shareholders was wishful thinking.
“我們對Enhabit的戰略審查程序在沒有出售公司的情況下結束感到失望。我們認爲這次失敗並不能反映Enhabit的內在價值或戰略潛力。相反，這種失敗在於Enhabit的董事會。3月，我們提名了七名高素質候選人蔘選2024年年會。我們選擇不公開披露提名，以避免干擾戰略審查流程，損害股東利益，但顯然，我們希望董事會最終能爲股東帶來積極成果，這是一廂情願。
We believe that Enhabit's lackluster operating performance relative to peers over the past two years plainly demonstrates that the Board urgently needs the deep operational expertise in home health and hospice that the AREX Slate would bring. The AREX Slate is eager to begin the work of driving improvement at Enhabit and maximizing value for all shareholders."
我們認爲，與同行相比，Enhabit在過去兩年中表現乏善可陳，這清楚地表明董事會迫切需要AREX Slate在家庭健康和臨終關懷方面所帶來的深厚運營專業知識。AREX Slate渴望着手推動Enhabit的改進，爲所有股東實現價值最大化。”
譯文內容由第三人軟體翻譯。